Intrahost dynamics of human cytomegalovirus variants acquired by seronegative glycoprotein B vaccinees

scientific article published on 19 February 2019

Intrahost dynamics of human cytomegalovirus variants acquired by seronegative glycoprotein B vaccinees is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JVI.01695-18
P932PMC publication ID6384057
P698PubMed publication ID30518646

P50authorKatia KoelleQ59750331
Cody NelsonQ83461201
Robert F PassQ84782486
Ravit Arav-BogerQ87822070
P2093author name stringSallie R Permar
Nathan Vandergrift
Marie Diener-West
Guanhua Xie
Michael Forman
Diana Vera Cruz
Melody Su
P2860cites workEstimation of levels of gene flow from DNA sequence dataQ24532834
On the probability of fixation of mutant genes in a populationQ24533316
The Average Number of Generations until Fixation of a Mutant Gene in a Finite Population.Q24533352
New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infectionQ24570109
Vaccine prevention of maternal cytomegalovirus infectionQ24645631
Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzeesQ27861060
Multiple sequence alignment using ClustalW and ClustalXQ29547698
MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequencesQ29617490
Incidence of cytomegalovirus infection among the general population and pregnant women in the United States.Q33289670
Strain-specific neutralization of human cytomegalovirus isolates by human sera.Q33640031
Detection of a single identical cytomegalovirus (CMV) strain in recently seroconverted young womenQ33802905
Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system.Q33850041
Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys.Q33877783
Extensive genome-wide variability of human cytomegalovirus in congenitally infected infants.Q33916640
A cladistic measure of gene flow inferred from the phylogenies of allelesQ33955939
B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodiesQ33996614
PEAR: a fast and accurate Illumina Paired-End reAd mergeR.Q34379012
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trialQ34786700
Rapid intrahost evolution of human cytomegalovirus is shaped by demography and positive selection.Q35004492
Within-host nucleotide diversity of virus populations: insights from next-generation sequencingQ35047735
Human cytomegalovirus pUS27 G protein-coupled receptor homologue is required for efficient spread by the extracellular route but not for direct cell-to-cell spreadQ35076539
Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infantsQ35463640
Comparative study of methods for detecting sequence compartmentalization in human immunodeficiency virus type 1.Q35857191
Limits and patterns of cytomegalovirus genomic diversity in humansQ35910248
Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trialQ36430938
Cytomegalovirus strain diversity in seropositive womenQ36497863
The "silent" global burden of congenital cytomegalovirusQ36558293
The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specificQ36691252
Genotypic analysis of two hypervariable human cytomegalovirus genesQ37134281
Cytomegalovirus infections in solid organ transplantation: a reviewQ37359332
Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection.Q39468421
Cytomegalovirus Kinetics Following Primary Infection in Healthy WomenQ40232738
A new statistic for detecting genetic differentiation.Q42552289
The product of human cytomegalovirus UL73 is a new polymorphic structural glycoprotein (gpUL73).Q42643557
Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccinesQ43656074
Monitoring cytomegalovirus infection by antigenemia assay and two distinct plasma real-time PCR methods after hematopoietic stem cell transplantationQ44214552
Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodiesQ44858818
SeekDeep: single-base resolution de novo clustering for amplicon deep sequencingQ46248684
Genetic content of wild-type human cytomegalovirusQ47709383
Cytomegalovirus glycoprotein B genotyping in ocular fluids and blood of AIDS patients with cytomegalovirus retinitis.Q47994551
Comparative analysis of sequence variation in gp116 and gp55 components of glycoprotein B of human cytomegalovirusQ48176380
The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genomeQ48264323
Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies.Q52568669
Analysis of mixed infections by multiple genotypes of human cytomegalovirus in immunocompromised patients.Q54489474
A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infectionQ57072187
Sequence variability of the ?-chemokine UL146 from clinical strains of human cytomegalovirusQ58473446
HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functionsQ59349089
Cytomegalovirus: genetic variation of viral genomesQ72889623
Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patientsQ80442556
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectCytomegalovirusQ6946
P577publication date2019-02-19
P1433published inJournal of VirologyQ1251128
P1476titleIntrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees
P478volume93

Reverse relations

cites work (P2860)
Q90062938Choice of Study Populations for Vaccines
Q90062898Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease
Q98664278Specificity and effector functions of non-neutralizing gB-specific monoclonal antibodies isolated from healthy individuals with human cytomegalovirus infection
Q91994540The Humoral Immune Response Against the gB Vaccine: Lessons Learnt from Protection in Solid Organ Transplantation